Education
About Us
Working with TipRanks
Follow Us
Grand Pharmaceutical Group Limited (HK:0512)
:0512
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | HK$ 11.64B | HK$ 10.53B | HK$ 9.56B | HK$ 8.60B | HK$ 6.35B |
| Gross Profit | HK$ 6.74B | HK$ 6.52B | HK$ 5.95B | HK$ 5.25B | HK$ 4.04B |
| Operating Income | HK$ 2.17B | HK$ 2.66B | HK$ 2.52B | HK$ 2.02B | HK$ 1.51B |
| EBITDA | HK$ 3.39B | HK$ 2.97B | HK$ 3.09B | HK$ 3.10B | HK$ 2.41B |
| Net Income | HK$ 2.47B | HK$ 1.88B | HK$ 2.08B | HK$ 2.40B | HK$ 1.79B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | HK$ 3.14B | HK$ 2.47B | HK$ 2.48B | HK$ 2.87B | HK$ 2.39B |
| Total Assets | HK$ 24.99B | HK$ 22.52B | HK$ 22.37B | HK$ 21.06B | HK$ 16.98B |
| Total Debt | HK$ 4.44B | HK$ 3.40B | HK$ 4.48B | HK$ 3.65B | HK$ 2.39B |
| Net Debt | HK$ 3.10B | HK$ 2.06B | HK$ 3.03B | HK$ 1.89B | HK$ 520.77M |
| Total Liabilities | HK$ 8.47B | HK$ 7.24B | HK$ 8.16B | HK$ 7.61B | HK$ 5.64B |
| Stockholders' Equity | HK$ 16.47B | HK$ 15.16B | HK$ 14.14B | HK$ 13.39B | HK$ 11.24B |
| Cash Flow | |||||
| Free Cash Flow | HK$ 1.28B | HK$ 1.93B | HK$ 245.79M | HK$ 1.49B | HK$ 1.31B |
| Operating Cash Flow | HK$ 1.90B | HK$ 2.42B | HK$ 1.92B | HK$ 2.12B | HK$ 1.78B |
| Investing Cash Flow | HK$ -2.00B | HK$ -515.75M | HK$ -2.58B | HK$ -2.05B | HK$ -2.05B |
| Financing Cash Flow | HK$ 29.96M | HK$ -1.89B | HK$ 464.49M | HK$ -195.08M | HK$ 899.79M |